ANTISENSE MODULATION OF RIBONUCLEASE L EXPRESSION

Details for Australian Patent Application No. 2002336471 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors WARD, Donna, T.; WATT, Andrew, T.

Pub. Number AU-A-2002336471

PCT Number PCT/US02/28729

PCT Pub. Number WO2003/023011

Priority 09/954,679 12.09.01 US

Filing date 9 September 2002

Wipo publication date 24 March 2003

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 09/954,679 12.09.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002336471

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336472-Inhibition of exoprotein production using aromatic compositions

2002336470-SEISMIC DATA ACQUISITION APPARATUS AND METHOD